Rentokil Initial (RTO)
(Delayed Data from NYSE)
$32.55 USD
+0.35 (1.09%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $32.54 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Income Statements
Fiscal Year end for Rentokil Initial PLC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 4,594 | 4,066 | 3,625 | 3,466 |
Cost Of Goods | NA | 4,172 | 3,589 | 3,248 | 3,127 |
Gross Profit | NA | 422 | 476 | 377 | 339 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 30 | 0 | 0 | -133 |
Income After Depreciation & Amortization | 0 | 392 | 476 | 377 | 472 |
Non-Operating Income | NA | 72 | 17 | 19 | 33 |
Interest Expense | NA | 98 | 46 | 101 | 73 |
Pretax Income | NA | 366 | 447 | 295 | 432 |
Income Taxes | NA | 79 | 85 | 56 | 70 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | 287 | 362 | 239 | 362 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | 287 | 362 | 239 | 362 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 852 | 863 | 753 | 844 |
Depreciation & Amortization (Cash Flow) | NA | 460 | 387 | 376 | 372 |
Income After Depreciation & Amortization | 0 | 392 | 476 | 377 | 472 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 402.80 | 373.26 | 372.58 | 372.10 |
Diluted EPS Before Non-Recurring Items | NA | 1.31 | 1.24 | 0.98 | 0.92 |
Diluted Net EPS (GAAP) | NA | 0.71 | 0.97 | 0.64 | 0.97 |
Fiscal Year end for Rentokil Initial PLC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |